Table 8 Results of a 26-week Trial of Liraglutide Injection as Add-on to Metformin and Sulfonylurea in Adult Patients with Type 2 Diabetes Mellitus a Liraglutide Injection Compared to Exenatide, Both as Add-on to Metformin and/or Sulfonylurea Therapy In this 26-week, open-label trial, 464 adult patients with type 2 diabetes mellitus on a background of metformin monotherapy, sulfonylurea monotherapy or a combination of metformin and sulfonylurea were randomized to once daily liraglutide injection 1.8 mg or exenatide 10 mcg twice daily
Chromonychia secondary to chemotherapy
Can men receive glutathione injections
To minimise confounding, the researchers applied propensity score overlap weighting, achieving well-balanced baseline characteristics
The activity of Foxo proteins is negatively regulated by the PI3K/Akt signaling pathway
While Ozempic is primarily used to help manage blood sugar levels in people with type 2 diabetes, it has been shown to promote weight loss as a secondary effect